We are live on ! Find out more
NXLIW

Nexalin Technology Inc Warrant

Delisted

NXLIW was delisted on the 19th of September, 2025.

8 hedge funds and large institutions have $81.2K invested in Nexalin Technology Inc Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.05% more ownership

Funds ownership: 10.32%10.37% (+0.05%)

0% more funds holding

Funds holding: 88 (0)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

48% less capital invested

Capital invested by funds: $155K → $81.2K (-$73.7K)

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$588

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$81
2
CS
Clear Street
New York
-$13
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Armistice Capital
New York
$30.9K +1 +0%
WAM
2
Warberg Asset Management
Illinois
$15.8K
BFM
3
Boothbay Fund Management
New York
$10.8K
ACM
4
Altium Capital Management
New York
$9.97K
CS
5
Clear Street
New York
$8.55K -$13 -100 -0.1%
Walleye Capital
6
Walleye Capital
New York
$3.71K
Citadel Advisors
7
Citadel Advisors
Florida
$1.48K +$588 +4,372 +39%
UBS Group
8
UBS Group
Switzerland
$9 -$81 -601 -86%

NXLIW Hedge Fund Activity: Q1 2023 in Review

8 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology Inc Warrant (NXLIW) for Q1 2023, worth a combined $81.2K — down 48% from $155K a quarter earlier.

Fund positioning in NXLIW was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $588. The largest seller was UBS Group, cutting an estimated $81.

  • 8 institutional investors held Nexalin Technology Inc Warrant (NXLIW) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $81.2K of Nexalin Technology Inc Warrant stock for Q1 2023, down 48% quarter-over-quarter.
  • 0 funds opened new Nexalin Technology Inc Warrant positions in Q1 2023 and 0 closed out.
  • The largest Nexalin Technology Inc Warrant buyer in Q1 2023 was Citadel Advisors, an estimated $588 added.
  • The largest Nexalin Technology Inc Warrant seller in Q1 2023 was UBS Group, an estimated $81 sold.

Based on aggregated 13F filings for Q1 2023.